Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles
In various embodiments nanoparticle drug delivery vehicles are provided that specifically deliver a cargo to a target pathogenic organism. In certain embodiments the drug delivery vehicle comprises a mesoporous silica nanoparticle comprising a plurality of pores and an outer surface through which the pores are disposed; a cargo disposed in the pores; one or more antigens attached to the surface of the nanoparticle; an antibody that specifically binds the antigens and are bound to the antigens, wherein the antibody inhibits diffusion of the cargo out of the pores and permit release of the cargo when the drug delivery vehicle is in the presence of the antigen or a pathogen displaying the antigen.
1. An antigen- or pathogen-specific delivery vehicle, said vehicle comprising:
a porous nanoparticle where said porous nanoparticle comprises a plurality of pores where said pores provide a pore surface inside the particle, and where said porous nanoparticle comprises an outer nanoparticle surface through which said pores are disposed;
a cargo disposed in said pores;
one or more antigens attached to the outer surface of said nanoparticle, wherein said one or more antigens each comprise a single tetrasaccharide unit of an O-antigen from a gram-negative bacterium; and
antibodies that specifically bind said antigens attached to the outer surface of said nanoparticle where said antibodies are bound to said attached antigens and inhibit diffusion of said cargo out of said pores and permit release of said cargo when said delivery vehicle is in the presence of a free form of said antigen or a pathogen displaying said antigen.
2. A pharmaceutical formulation, said formulation comprising:
a vehicle of claim 1 ; and
a pharmaceutically acceptable carrier/excipient.
3. The delivery vehicle of claim 1 , wherein said antigen is acetylated.
4. The delivery vehicle of claim 1 , wherein said porous nanoparticle comprises a particle selected from the group consisting of a mesoporous silica nanoparticle, mesoporous hollow silica nanoparticle, and a mesoporous organosilica nanoparticle.
5. The delivery vehicle of claim 1 , wherein said cargo comprises a detectable label or an agent that kills a microorganism.
6. The delivery vehicle of claim 1 , wherein said antigen is acetylated.
7. The delivery vehicle of claim 1 , wherein said porous nanoparticle comprises a particle selected from the group consisting of a mesoporous silica nanoparticle, mesoporous hollow silica nanoparticle, and a mesoporous organosilica nanoparticle.
8. The delivery vehicle of claim 1 , wherein said cargo comprises a detectable label selected from the group consisting of an enzymatic label, a substrate for an enzymatic label, a fluorophore, a colorimetric label, and a radioactive label.
9. The delivery vehicle of claim 1 , wherein said antigen comprises a single O-antigen serotype.
10. The delivery vehicle of claim 1 , wherein said antigen comprises a plurality of O-antigen serotype(s).
11. The delivery vehicle of claim 1 , wherein said antigen comprises an O-antigen selected from the group consisting of Franciscella O-antigen, Acinetobacter O-antigen, Actinobacillus O-antigen, Bordetella O-antigen, Brucella O-antigen, Campylobacter O-antigen, Cyanobacteria O-antigen, Enterobacter O-antigen, Erwinia O-antigen, Escherichia coli O-antigen, Helicobacter O-antigen, Hemophilus O-antigen, Klebsiella O-antigen, Legionella O-antigen, Moraxella O-antigen, Neisseria O-antigen, Pasteurella O-antigen, Proteus O-antigen, Pseudomonas O-antigen, Salmonella O-antigen, Serratia O-antigen, Shigella O-antigen, Treponema O-antigen, Vibrio O-antigen, and Yersinia O-antigen.
12. An antigen- or pathogen-specific delivery vehicle, said vehicle comprising:
a porous nanoparticle where said porous nanoparticle comprises a plurality of pores where said pores provide a pore surface inside the particle, and where said porous nanoparticle comprises an outer nanoparticle surface through which said pores are disposed;
a cargo disposed in said pores, where said cargo comprises a detectable label;
one or more antigens attached to the outer surface of said nanoparticle, wherein said one or more antigens comprise a single tetrasaccharide unit of an O-antigen from a gram-negative bacterium; and
antibodies that specifically bind said antigens attached to the outer surface of said nanoparticle where said antibodiesand are bound to said attached antigens and inhibit, diffusion of said cargo out of said pores and permit release of said cargo when said delivery vehicle is in the presence of a free form of said antigen or a pathogen displaying said antigen.
13. The delivery vehicle of claim 12 , wherein said porous nanoparticle comprises a particle selected from the group consisting of a mesoporous silica nanoparticle, mesoporous hollow silica nanoparticle, and a mesoporous organosilica nanoparticle.
14. The delivery vehicle of claim 12 , wherein said cargo comprises a detectable label selected from the group consisting of an enzymatic label, a substrate for an enzymatic label, a fluorophore, a colorimetric label, and a radioactive label.
15. The delivery vehicle of claim 12 , wherein said antigen comprises a single O-antigen serotype.
16. The delivery vehicle of claim 12 , wherein said antigen comprises an O-antigen selected from the group consisting of Franciscella O-antigen, Acinetobacter O-antigen, Actinobacillus O-antigen, Bordetella O-antigen, Brucella O-antigen, Campylobacter O-antigen, Cyanobacteria O-antigen, Enterobacter O-antigen, Erwinia O-antigen, Escherichia coli O-antigen, Helicobacter O-antigen, Hemophilus O-antigen, Klebsiella O-antigen, Legionella O-antigen, Moraxella O-antigen, Neisseria O-antigen, Pasteurella O-antigen, Proteus O-antigen, Pseudomonas O-antigen, Salmonella O-antigen, Serratia O-antigen, Shigella O-antigen, Treponema O-antigen, Vibrio O-antigen, and Yersinia O-antigen.
17. The delivery vehicle of claim 12 , wherein said cargo comprises a fluorophore or an enzymatic label, or a substrate for an enzymatic label.
18. A method of preparing a delivery vehicle, said method comprising:
providing a porous nanoparticle comprising a plurality of pores and an outer surface through which said pores are disposed and an antigen attached to the surface of said nanoparticle, wherein said antigen comprises a single tetrasaccharide unit of an O-antigen from a gram-negative bacterium;
loading a cargo into the pores comprising said porous nanoparticle; and
contacting said nanoparticle with an antibody that binds to said antigen thereby sealing said cargo into the pores of said nanoparticle.